SKI Market

Indian Indices

Nifty

24,565.35 -203.00
(-0.82%)

Sensex

80,599.91 -585.67
( -0.72%)

Bank Nifty

55,617.60 -344.35
( -0.62%)

Nifty IT

34,649.60 -652.00
( -1.85%)

Global Indices

Nasdaq

44,167.41 -314.88
(-0.71%)

Dow Jones

6,364.11 -19.79
(-0.31%)

Hang Seng

40,837.80 -232.02
(-0.56%)

Nikkei 225

9,068.58 -64.23
(-0.70%)

Forex

USD-INR

87.43 0.51
(0.59%)

EUR-INR

100.57 0.11
(0.10%)

GBP-INR

116.43 0.45
(0.39%)

JPY-INR

0.59 0.00
(0.53%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

345.7618998

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

14.77

101785.59

EPS(TTM)

Face Value()

Div & Yield %

82.6

0.66

Back

Hindustan Unilever consolidated net profit rises 5.59% in the June 2025 quarter

Jul 31,2025

Net profit of Hindustan Unilever rose 5.59% to Rs 2756.00 crore in the quarter ended June 2025 as against Rs 2610.00 crore during the previous quarter ended June 2024. Sales rose 5.15% to Rs 16323.00 crore in the quarter ended June 2025 as against Rs 15523.00 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	16323.00	15523.00	5
OPM %	22.77	24.11	-
PBDT	3791.00	3906.00	-3
PBT	3430.00	3577.00	-4
NP	2756.00	2610.00	6

24,565.35 -203.00 (-0.82%)

80,599.91 -585.67 ( -0.72%)

55,617.60 -344.35 ( -0.62%)

34,649.60 -652.00 ( -1.85%)

44,167.41 -314.88 (-0.71%)

6,364.11 -19.79 (-0.31%)

40,837.80 -232.02 (-0.56%)

9,068.58 -64.23 (-0.70%)

87.43 0.51 (0.59%)

100.57 0.11 (0.10%)

116.43 0.45 (0.39%)

0.59 0.00 (0.53%)